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TIw wertty or the infarct-related residual coronary steno- 
sis alter spontaneous or lherapeutic thrombolysir was 
sunntltatlvelv asses& in 91 patients with nn acute myn- 
&dipl inf&lion who were &wsted to hpatmcnt in ;he 
acute stage with either a thrombotytic agnt WI me of 
reed&m, ti$s”Rtyp plaslni.ogei BP,iY~tor gi,en over 3 
b, 49 patients) r~r a placebo (42 patienrs). Heparin and 
asp&in ware given to both groups until angiopphy UBE 
performed. Digitat subtracted images of the infarct.rrlated 
coronary vcsset were obtained 10 to I4 days atIer haspitat 
admt.atanand were subsequcntty analyzed wtth the use ofo 
eomputervxststed ornary stenosis meawrement qrtem. 
Nettbrr treatmat grcmp dtllered significantly in age. 
gaiter or kc&a of the culprit coronary lesion. Median 
v~luts (90% range) in the thmmlwlysis and control groups 
were, respectively, 1.95 (0.9 to 5.3) mm wsus 1.7 (0.9 !(I 
3.4) mm lor s(tnwis len~U& 1.4 (0.8 to 2.7) nnn vernn 1.4 
(0.9 to 1.8) mm r0r minimat uminat diameter: 576 (3646 
High patency rates of the infarct-related coronary artery 
(ranging from 41% to 77%) ar rl week after an acute 
mywardial infarction have been reported (l-9) in patients 
with infarction whodid not receive thromboiytic therapy but 
were treated with heparin or anliplatelet drugs. or both. 
These findings suggest that gradua! endagenous fitrinolysis 
occurs in many of these patients. The Eurepean Cooperative 
Study Group (9) reported an 83% pates-y n:e (Thromboly- 
sis in Mywardial Infarction [TM] grade 2 or :i :C il) 22 
days after treatment with intravenous recombinanr tissuc- 
type plasminogen activator &t-PA). This rate ws only 
slightly higher than the 71% rate iuund in control patients in 
the ~me nr&icenter trial who did not receive thromhalytic 
therapy. Both groups in that trial (9) received heparin and 
aspirin from the time of hospital admissior! until nngiograp>!~ 
WI perfnrmcd. Therefox. tbc combined and prolo~~ged 
administration of these two agents in that trial might explain 
the higher proportion of open vessels in contrnl patients 
compared with the corresponding groups in other placebo- 
controlled trials of thmmbolyric therapy (1-g). 
It is unknown whether spontaneous lysis of coronwy 
artery thrombur in the absence of thrombolytic therapy is as 
complete as that induced by the early administration of 
thrombolyrx agents. It is possible that gradual endogenous 
tibrinolyus. although capable of recanalizing a high percent 
of obstructed coronary arteries, is associated with more 
r&dual thrombosis and lhercfore a more severe residual 
coronary auosis and an increased risk of subsequent reoc- 
Msnurclipt rcceivrd h”“ary 10. ,890. revid mr”“rc‘lpl rcccl”d June 
6. ,990. acrewd J”?C 19. ww. ciuion. 
-for nanr “an dr WC*. w Dwrwn of catd!ologY. The am of this study was to compare quantitatively. with 
Cnivenity Hospital Garlhuiibep. Horenru~ 19. B-ICUO Lcuven. Brlpum the aid of digital subtraction techniques. the anatomy and 
severity of rhe residual coronary stenosis at the 1%~ of 
hospital discharge in patients with a patent infarct-related 
coronary artery who were randomized in the acute stage of 
myocardial infarction to receive r&PA or placebo therapy. 
Both trcatmem groups also received heparin and aspirin. 
Methods 
Sludy patients. Patients recruited in 13 Belgian hospitals 
palticipating in the European Coopcm~ive T&l (9) of n-PA 
versus placebo were considered for this angiographic study. 
The inclusion and exclusion criteria of this trial have been 
dcscnbcd in detail previously (9). Briefly, patients between 
21 and 71 years ofaga with chest pain typical of myocardial 
ischemia were eligible provided that I) the trial treatment 
could be started within 5 h after the onset of symptoms, 2) 
the electrocardiographic (ECO) inclusion criteria were ful- 
filled, and 3) no contraindications for thrombolyttc therapy 
were present. 
Treatment allcation. All patients received 250 mg of 
aspirin and S,GiHl IU of heparin immediately before admin- 
istration ofthe trial medication was begun. Patients allocated 
to thrombolytic treatment were given a bolus injection of IO 
mg of II-PA hollowed by an additional 50 mg during I hand 
40 mg during thz next 2 h. In the control group, a matching 
placebo infusion was given in exactly the same way. After 
administration of the trial medication, all patients were 
treated with heparin (l.O1?0 NJ/h after a bolus injection of 
S.oW IU) and aspirin (75 to I25 mg orally given every other 
day) until angiography was performed. Any other treatment 
was given only if clinically indicated. 
Quantitative nn%ograp$. Between IO and 14 days after 
treatment allocation, coronary artcriography and left ven- 
tricular angiography were performed. During these studies. 
the infarct-related coronary artery was identified by an 
experienced angiographcr with the help of the available 
EC&. In patienis with complete reperfusion (TIM1 grade 3). 
digital images of the infarct-related vessel were acquired and 
stored at 50 fwmeslr with a 512 x 512 x IO bit pixe! azttir 
(Digitron, Siemens;. From !bese. end-diastolic images show- 
mg the smallest luminal diameter of the culprit lesion were 
selected and stored on floppy disks for later analysis by an 
independent observer who was unaware of which trial 
treatment he patient had received. 
We used o srrninuromnric analyzing s.wem. The user had 
to dclinc the scan width and trace a visually estimated 
centerline of the coronary vessel. Further analysis was 
performed autumalically by the computer. The first step was 
edge detection filtering to increase contrast at the edges. 
Thereafter. the s~ructurc likelihood matrix was constructed. 
This wasdone by detecting the preliminary edge points using 
a weighted sum of first and second derivatives and by 
redefining the centerline and scanlines perpendicular to the 
optimal centerline. Ultimate image processing was achieved 
Figure 1. AutomStie calculation of the r&race diameter (DIA.). 
length tLEN.) of the stenosis. minimal luminal diameter, percent 
diameter obstruction and percent geometric and denritometric area 
obstruction on a digital substraction image of a rep&red infarct- 
related right coronary artery lesion. 
in four steps. In step I, two-dimensional median filtering was 
pctfomwd to reduce noise and to obtain a more homoge- 
neous picture with preservation of the edges: in step 2, a 
dynamic search algorithm was applied to stress the global 
trends in the data; and in steps 3 and 4. a three point 
smoothing technique and an average background subtraction 
were used. Finally, the borders of the vessel under study 
were traced with use of this end matrix. Once the borders 
were obtained. the user had to define a reference area and 
the +znotic a~ca under study; then the len 
“r 
of the stenosis 
(mml. its minimal lominal diameter (mm. the reference 
diameter (mm), the percent diameter obstruction and the 
percent area obstruction. either geometric or densitometric, 
were calculated aaddisplayedona videoscreen(Fig. I). The 
tip of the catheter was used for calibration. 
StatlsticaJ analysis. The chi-square test was performed to 
analyze categoric vaiablcs. Coronary measurements are 
reported as median and 90% range values. Ditierences 
between the two treatment groups were analyzed by the 
Mann-Whitney rank-sum test. All p values were two-tailed, 
and statistical significance was defined as a p value of <O.OS. 
Results 
Sludy groups (Tables 1 and 2). Of a total of 312 Belgian 
patients who entered the European trial (9). 291 underwent 
angiography at University Hospital Gasthuistcrg ip. Lcuvcn. 
In 16 patients 6%). the infarct-related coronary vessel could 
not be identified. Of the remaining 275 patients, 207 (75%) 
had a TIM1 grade 3 open infarct-related vessel; 91 of these 
patients were selected for qoantitative analysis (Table Il. Of 
the 201 patients with an identified TIM1 grade 3 open 
infarct-related vessel. II6 (56%) were excluded: m 42 of 
these (30 r&PA. I2 placebo). no digital mnges were made 
because of technical or organizational problems lfor eum- 
pie. catheterization laboratory with digital equipment not 
available); and in 14 patients I34 n-PA. 40 placebo). the 
digital images of the infarct-related coronvry artery were not 
uitablc for quantitative stenosis measurement (for exiample. 
mul~plc CU~SCCUIIYC IeGons. mrcrfcring ride branches and 
inwfficwu hackground subtraction). Thequanlitnliveasgia- 
graphic analyrn wils performed m the r:mGwg9l pa!.rn!s. 
of whom -I9 were given r&PA and 42 placebo. 
There WE an CXCBES of right coronary arrery lesions in 
the iwo group\. ecpecially m control patients. Thi5 predom- 
inance of nghf coronary artery disease was also observed in 
the total group studied (Table I) and might be explained by 
the \tr,c, emry KG cnteria (a3 mV in a, l:asf Iwo precoi- 
dual leads) required for anterior infarctmn (91. 
Thcrc were no significant differences between the IWO 
analvzed ~rouos in mean see. tender. location of the inla!cl- 
rel&d c&n&y l&m and number of coronary vessels vilh 
aienificant lesions (~50% diameter clcnos~s) (Table 21. 
_ Angiographic aswssmenl of the infarct-r&led coronary 
stenosis (Tab!e 3). Reference diameter. minimal luminal di- 
ameler. stenosis length. diameter obslrucliun and geometric 
and densitometric area obstruction in the wo groups were 
compared. No significant differences were famd betwszn 
the two groups. 
In 68 (75%l of the 91 patients. a ?50% residual diameter 
stenosis was present. The percent of patient- with r5OW or 
~70% residual diameter stenosis was slightly bigher in the 
placebo group than in the n-PA group. although lhesc 
differences were s@tisdcally not significant: a residual sle- 
noG of ~70% was present in 8 116%) II-PA- and 5 112%) 
placebo-treated patients; 26 patients (53%) in ihe rl-PA 
group and 29 (69%) in the placebo group had a stenosis 
diameter between 50% and 70%: <50% diameter stenosis 
uas found in I5 (31%) and 8 (IW patients in the n-PA and 
the placebo group. rcspcctwcly. 
the high Incidence of open coronary vessels (up IO 77%) at 
tl week after acute myocardial infarction in the control 
patients of Ibrombolysis trials (I-9). This striking difference 
in patency rale of the infarct-related vessel between admis- 
sion and discharge can be attributed to gradual endogenous 
fihrinolysis and to prevention ofrethrombosis by the admin- 
istration ofantithrombotic therapy (heparin. warfain. attti- 
platelet drugs). 
The prescncc ofa patent infarct-related vessel at the time 
of hospital discharge is of great clinical significance because 
it is one of the most zmporumt independent predictors of late 
survival (I 1.12). II is unknown whether the anatomy of the 
infarct-related residual coronary stenosis at the time of 
hospital discharge differs significantly between patients who 
were given Ihrombolytic therapy in addition to antithrom- 
botic therapy and those given antithromhotic therapy alone. 
The answer 10 this question might have important implica- 
tions for further therapy because reocclusion and reinfarc- 
lion might occur more frequently in the setting of a tight 
residual stenosis or residual thrombosis. In this study. we 
used digital subtraction techniques to analyze the residual 
infarct-related coronarv lesion in 91 oatients who were eiven 
n-PA or placebo in th; acute stage bf myacardial infarction 
in addition IO asoirin and heoarin and who attained TIM1 
grade 3 reperf&on. Aspirin’and heparin were continued 
during the hospital stay until angiography was performed IO 
IO 14 days after admission. The anatomy of the culprit lesion 
was measured with the aid of a computer-assisted coronary 
stenosis mes~ilrcment system by an Independent observer 
who was unaware of the trial lreatment given. 
Severity OF the infarct-related r&dual coronary lesion. In 
the thrombolysir group. the median values for minimal 
luminal diameter, percent diameter and area obstruction of 
the coronary lesion were not different from those obtained in 
the ~on’rol group and were very similar to those obtained in 
other stud& with inIracoron&y strepiokinase (131 and in- 
Iravenotts dodble chain r&PA (14). This observation con- 
firms and Funher extends the findings of Rentrop et al. t I). 
Indeed, our srudy shows that cormol patients receiving 
prolonged and intensive antithromhotic treatment (aspirin 
and heparin) not only have a high patency rate of the 
infarct-related coronary artery 2 weeks after the acute event. 
but also have a residual stenosts of a severity similar to that 
after Ihrombolytic therapy. 
Late changes in the size of the coronary iesioo after 
successful Ihrambolysis have bees described IIS). These 
changes have been artributed to reendothelialiration of the 
ruptured plaque. re,orpIion of associate hemorrhage. disso- 
lutton of residual thrombus BE a result of continuing fibrino. 
lyds and altered vasontotor tone due to loss of enda!helial 
integrity (1% In view of our findings. these processes seem 
to intervene to a simdar extent whether or not thrombolytic 
agents are given in the acute atage. 
Our f.nding, indirectly indicate that the demonstrated 
beneficial effects of early Ihrombolytic therapy on infarct 
size, preservation of left ventricular function and survival 
must be attributed to an earlier dissolution of coronary 
thrombus and a more rapid recanalization of the infarct- 
related vessel than occtu with endogeneous fibrinolysis 
because no significant differences in the anatomy of the 
residual coronary stenosis were found between Ihr ~:i’o 
treatment groups IO to 14 days after the acute event. 
Limitationsof Ihesludy. A selection bias may have been 
in:roduced because only patients with a patent coronary 
vessel and an infarct-related coronary lesion suitable for 
quantitative analysis were studied. However. a similarly 
high proportion of paten! vessels was found in the two 
treatment groups at IO to I4 days after the acute event and 
the identification of the infarct-related coronary artery, the 
selection of the culprit lesion for subseauent analysis and the 
analysis itself we; performed withotti knowle$e of Ireat- 
ntent allocation. Cunhermore. we used digital subtraction 
techniques and a computer-assisted measurement system, 
which should allow a more objective and reproducible 
quantification of the coronary lesions. 
The ore of (1 sin.& projection showinn the smallesr 
lwninol diameter is another fimitotion of the study. To 
overcome this limitation. we also performed a densitomelric 
analysis. whose resttlts were verv similar to those of the 
geometric analysis. 
Clinical imdications and condvsions. In this studv. the 
combined ad&stration of hepwin and aspirin in &dents 
with acute mywardial infarction resulted not only in a high 
comnary artery patency rate at angiography perfotmed 10 to 
I4 days after the acute event. but also in a residual infarct- 
related coronary lesion of similar anatomy and severity 85 
that observed in patients who were also given Ihmmbolytic 
therapy. These similarities should be interpwed as the 
result of I) time-dependent processes ofgradual endogenous 
or rapid therapeutic thrombolysis followed by stenosis re- 
modeling. and 2) the prevention of rethromhosis by an 
effective antithrombotic Ireatment (aspirin and heparin). in 
view of these time-consuming processes, routine coronary 
angiography should not be performed during the first days 
allcr the acute event in clinically stable patients with acute 
myocardial infarction. 
Whether cardiac catheterization should he wformed rou- 
tinely in patients afier an acute myocardial it&ion is still a 
conIr~versial issue. The findine that 75% of the oatients had a 
significant residual infarct-r&&d coronary sten&is favors the 
use of routine angiognphy. However. such an elecdve angio- 
graphic evaluation must he performed sufficiently late after 
iniarction 10 allow proper determination of the residual anat- 
omy of the underlying aIhemscleroIic disease. 

